Issue Panel Submission Information

ACCESS TO ONLINE SUBMISSION SYSTEM:

WEDNESDAY, 1 NOVEMBER 2017

ABSTRACT SUBMISSION DEADLINE:

WEDNESDAY, 14 MARCH 2018

ACCEPTANCE NOTIFICATION:

 TUESDAY, 1 MAY 2018

GENERAL INFORMATION

  • All research abstract, workshop and issue panel proposal submissions and presentations must be in English.
  • All research abstract, workshop and issue panel proposal submissions and presentations must not promote any product or service.
  • Expenses associated with the submission and presentation of an abstract are the responsibility of the presenter.
  • Meeting registration is required for all presenters.
  • The presenters of research are required to disclose financial support. Abstract review will NOT be based on this information.
  • Research abstract, workshop and issue panel proposal submissions, excluding title and author information, should be no longer than 300 words.
  • The use of tables and graphs in your research abstract submission, workshop or issue panel proposals, or case studies are not allowed.
  • Generic names should be used for technologies (drugs, devices), not trade names.
  • A research abstract that was accepted for another meeting and copyright has been transferred cannot be submitted to an ISPOR meeting.
  • Research presented at a previous ISPOR meeting is not allowed.
  • Multiple abstracts on the same study are discouraged.

ISSUE PANEL PROPOSAL INFORMATION

  • Issue Panels are designed to stimulate real debate on new or controversial issues in health economic/pharmacoeconomic and outcomes research or use of outcomes research in health care decision-making.
  • An issue panel is composed of a moderator and 2 to 3 panelists.
  • To assure lively debate, panelists and/or moderator should be from different institutions and/or work environments representing different perspectives on the debate.
  • Panelists should present distinct views about the topic.
  • Issue Panel proposals must be organized as follows:
    • TITLE: Full title of your Issue Panel (showing the debate issue in the title is recommended)
    • MODERATOR AND/OR CONTACT PERSON: Name, degrees, position, and full contact information for the Moderator of the Issue Panel
    • PANELISTS: Names, degrees, positions, and full contact information for the Issue Panelists. A maximum of three panelists is permitted. Each panelist should represent a different point of view.
    • ISSUE: A clear definition of the issue should be described indicating the perspectives to be presented (with panelists named for each perspective).
    • OVERVIEW: Background information on the issue(s) should be included.
  • Accepted proposals are published AS SUBMITTED in the Meeting Program and Schedule of Events.

STEP 1: TITLE AND ISSUE PANEL PERSPECTIVE

When submitting your proposal, titles must be submitted in all CAPS. You must also provide the question which will be debated by the panelists.

 

STEP 2: TOPICS FOR ISSUE PANEL SUBMISSIONS:

When submitting your proposal, you must select a topic that best describes your issue panel.

 

TOPICS FOR ISSUE PANEL PROPOSAL

Issue Panel submissions are accepted on the following TOPICS:

  • Health Policy Development Using Outcomes Research Issues
  • Use of Real World Data Issues
  • Clinical Outcomes Research Issues
  • Economic Outcomes Research Issues
  • Patient-Reported Outcomes & Patient Preference Research Issues

CRITERIA FOR EVALUATION OF THE ISSUE PANEL

  • Is the issue panel clearly a debate on an issue?
  • Is the issue clearly defined?
  • Is more than one perspective identified?
  • Is the background information (included in the overview) clear and concise?
  • Is there time allotted for audience discussion and debate?
  • Please rate the importance of this subject to be included in this year’s scientific program

Abstract Submission Instructions | 8th Asia Pacific Conference main page

Contact ISPOR @ info@ispor.org | View Legal Disclaimer
© 2018 International Society for Pharmacoeconomics and Outcomes Research.
All rights reserved under International and Pan-American Copyright Conventions.